Koji Igarashi
Ayase, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Evidence Supporting Autotaxin as a Potential New Drug Treatment Target in Patients With Advanced Diabetic Retinopathy.
Journal: Investigative ophthalmology & visual science
Published: December 16, 2025
Serum Autotaxin Levels Predict Liver-Related Events in Patients With Primary Biliary Cholangitis: A Long-Term Multicenter Observational Study.
Journal: Clinical and translational gastroenterology
Published: July 29, 2024
Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease.
Journal: Communications medicine
Published: September 26, 2023
Autotaxin is a potential predictive marker for the development of veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation.
Journal: Annals of hematology
Published: September 14, 2023
Decrease in serum levels of autotaxin in COVID-19 patients.
Journal: Annals of medicine
Published: November 12, 2022
A Diagnostic Impact of Serum Autotaxin Levels in Patients with Bone Marrow Fibrosis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 07, 2022
Utility of serum autotaxin levels for predicting post hepatectomy liver failure in hepatocellular carcinoma.
Journal: Journal of hepato-biliary-pancreatic sciences
Published: August 14, 2022
Role of Autotaxin in High Glucose-Induced Human ARPE-19 Cells.
Journal: International journal of molecular sciences
Published: July 25, 2022
The diagnostic and prognostic value of mature and total adrenomedullin for sepsis: a prospective observational study.
Journal: Anaesthesiology intensive therapy
Published: February 01, 2022
Last Updated: 09/26/2026